Combination is better than monotherapy with ACE inhibitor or angiotensin receptor antagonist at recommended doses

Combination is better than monotherapy with ACE inhibitor or angiotensin receptor antagonist at recommended doses

Objective The combination of an angiotensin-converting enzyme (ACE) inhibitor and an angiotensin II (Ang II) receptor antagonist (ARB) could provide a higher degree of blockade of the renin-angiotensin system(RAS) than either agent alone. The primary aim of this study was to look at the effect of th...

Full description

Bibliographic Details
Main Authors:	Julián Segura, Manuel Praga, Carlos Campo, José L Rodicio, Luis M Ruilope
Format:	Article
Language:	English
Published:	SAGE Publications 2003-03-01
Series:	Journal of the Renin-Angiotensin-Aldosterone System
Online Access:	https://doi.org/10.3317/jraas.2003.007

Similar Items

ACE inhibitors, angiotensin receptor antagonists and bradykinin
by: Michael Schachter
Published: (2000-03-01)

Comparing recommended doses of angiotensin receptor blockers and ACE inhibitors (CORD Study)
by: J. Spinar, et al.
Published: (2009-08-01)

Review: ACE inhibition or angiotensin receptor blockade: which should we use in diabetic patients?
by: Luis M Ruilope, et al.
Published: (2003-06-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES
by: E. M. Khurs, et al.
Published: (2016-01-01)

Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
by: McMurray, J, et al.
Published: (2005)

[Prevention with angiotensin-converting enzyme (ACE) inhibitors]
by: Ertl, G, et al.
Published: (1992)

Prevention with angiotensin-converting enzyme (ACE) inhibitors
by: Ertl, G, et al.
Published: (1992)

RU28318, an Aldosterone Antagonist, in Combination with an ACE Inhibitor and Angiotensin Receptor Blocker Attenuates Cardiac Dysfunction in Diabetes
by: Ibrahim F. Benter, et al.
Published: (2013-01-01)

Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure.
by: Andrea Kuenzli, et al.
Published: (2010-04-01)

Combination of aliskiren with angiotensin-converting enzyme-inhibitor and angiotensin receptor blocker — mechanism of action
by: Luis M Ruilope
Published: (2008-03-01)

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection
by: M. L. Maksimov, et al.
Published: (2010-04-01)

Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial
by: Joanna Suliburska, et al.
Published: (2018-09-01)

Angiotensin II receptor antagonist and ACE inhibitor effectiveness in cognitive function correction among elderly patients with arterial hypertension
by: S. V. Nedogoda, et al.
Published: (2007-06-01)

ACE inhibitors &ndash; angiotensin II receptor antagonists: A useful combination therapy for ischemic heart disease
by: T S Mohamed Saleem, et al.
Published: (2010-07-01)

Direct Renin Inhibitor is Better than Angiotensin II Receptor Blocker for Intrarenal Arterioles
by: Yohko Nagai, et al.
Published: (2016-08-01)

ACE inhibitor and angiotensin receptor-II antagonist prescribing and hospital admissions with acute kidney injury: a longitudinal ecological study.
by: Laurie A Tomlinson, et al.
Published: (2013-01-01)

Combined therapy of arterial hypertension: focusing on a fixed-dose calcium antagonist/ACE inhibitor combination
by: D. V. Preobrazhensky, et al.
Published: (2008-08-01)

Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
by: Oghenemega Okoloko, et al.
Published: (2021-11-01)

Does Angiotensin (1-7) Contribute to the Antiproteinuric Effect of ACE-inhibitors?
by: Els A van der Wouden, et al.
Published: (2005-06-01)

Interaction of -blockers and angiotensin receptor blockers/ACE inhibitors in heart failure
by: Jay N Cohn
Published: (2003-09-01)

MECHANISMS OF COMBINED ACTION OF ACE INHIBITORS AND CALCIUM ANTAGONISTS IN ARTERIAL HYPERTENSION
by: E. I. Astashkin, et al.
Published: (2013-06-01)

ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients
by: Ahmed Daoud, et al.
Published: (2021-01-01)

Amadori compounds as potent inhibitors of angiotensin-converting enzyme (ACE) and their effects on anti-ACE activity of bell peppers
by: Jiahao Yu, et al.
Published: (2016-12-01)

Review: Effect of combining angiotensin receptor blockers and ACE inhibitors on cardiovascular disease
by: Trefor Morgan
Published: (2001-03-01)

Angiotensin-converting enzyme inhibitors in lipid metabolism and atherosclerosis: An ace up the sleeve?
by: Dilip Gude
Published: (2014-01-01)

Angiotensin Converting Enzyme (ACE) Inhibitor Extends Caenorhabditis elegans Life Span.
by: Sandeep Kumar, et al.
Published: (2016-02-01)

Synthesis of angiotensin-converting enzyme (ACE) inhibitors: an important class of antihypertensive drugs
by: Lima Dênis Pires de
Published: (1999-01-01)

The Yin and Yang of ACE/ACE2 Pathways: The Rationale for the Use of Renin-Angiotensin System Inhibitors in COVID-19 Patients
by: Loris Zamai
Published: (2020-07-01)

Effects of a fixed-dose combination of ACE inhibitor and nondihydropyridine calcium antagonist on endothelial dysfunction in patients with essential arterial hypertension
by: O. D. Ostroumova, et al.
Published: (2010-04-01)

Dual blockade of the renin-angiotensin system: are two better than one?
by: Haynes, R, et al.
Published: (2009)

Angiotensin II antagonists
by: David García Barreto, et al.
Published: (2014-03-01)

Persistent formation of angiotensin II despite treatment with maximally recommended doses of angiotensin converting enzyme inhibitors in patients with chronic heart failure
by: Sam Hanon, et al.
Published: (2000-06-01)

Combined treatment of arterial hypertension: focus on calcium antagonist and ACE inhibitor combination
by: V. I. Makolkin
Published: (2008-12-01)

Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients
by: Ikram Omar Osman, et al.
Published: (2021-06-01)

Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade.
by: Chih-Ching Lin, et al.
Published: (2017-01-01)

Debatable points of using angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in patients with COVID-19
by: O. M. Drapkina, et al.
Published: (2020-07-01)

Dose response of ACE inhibitors: implications of the SECURE trial
by: Lonn Eva
Published: (2001-07-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
by: K. A. Ghyamdzhyan, et al.
Published: (2022-12-01)

Angiotensin converting enzyme (ACE) and ACE2 bind integrins and ACE2 regulates integrin signalling.
by: Nicola E Clarke, et al.
Published: (2012-01-01)

Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease.
by: Kunz, R, et al.
Published: (2008)